CIK 0001645460 · Non-accelerated filer<br>Smaller reporting company
Cue Biopharma, Inc.
Sign in to watch- Ticker
- CUE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473324577
- Phone
- 617-949-2680
- Business address
- 100 CHESTNUT STREET, SUITE 300, SOMERVILLE, MA, 02143
- Former names
- Imagen Biopharma, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $389,304
- in 3 filings
Net −$389,304. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 20 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-08-03 | Sandercock Colin SVP, General Counsel and Sec | Option exercise · Stock Option (right to buy) | −6,425 | 143,575 | ||
| 2020-08-03 | Suri Anish President and CSO | Option exercise | +2,000 | $8.26 | $17K | 36,558 |
| 2020-08-03 | Suri Anish President and CSO | Option exercise | +3,800 | $6.42 | $24K | 40,358 |
| 2020-08-03 | Suri Anish President and CSO | Sale | −5,800 | $20.01 | $116K | 34,558 |
| 2020-08-03 | Suri Anish President and CSO | Option exercise · Stock Option (right to buy) | −2,000 | 18,000 | ||
| 2020-08-03 | Suri Anish President and CSO | Option exercise · Stock Option (right to buy) | −3,800 | 146,200 | ||
| 2020-06-24 | Fletcher Aaron G.L. Director | Purchase | +4,547 | $24.64 | $112K | 155,499 |
| 2020-06-24 | Fletcher Aaron G.L. Director | Purchase | +2,953 | $25.24 | $75K | 158,452 |
| 2020-05-11 | Morich Frank Director | Grant or award · Stock Option (right to buy) | +1,200 | 1,200 | ||
| 2020-03-31 | Suri Anish President and CSO | Option exercise | +16,666 | 39,912 | ||
| 2020-03-31 | Suri Anish President and CSO | Shares withheld for taxes | −5,354 | 34,558 | ||
| 2020-03-31 | Suri Anish President and CSO | Grant or award · Restricted Stock Units | +50,000 | 116,667 | ||
| 2020-03-31 | Suri Anish President and CSO | Option exercise · Restricted Stock Units | −16,666 | 100,001 | ||
| 2020-03-24 | Pienta Kenneth Chief Medical Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2020-02-05 | Sandercock Colin SVP, General Counsel and Sec | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2020-02-05 | Millar Kerri-Ann VP-Finance | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2020-02-05 | Suri Anish President and CSO | Grant or award · Stock Option (right to buy) | +65,000 | 65,000 | ||
| 2020-02-05 | PASSERI DANIEL R CEO | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2020-02-05 | PASSERI DANIEL R CEO | Grant or award · Restricted Stock Units | +150,000 | 150,000 | ||
| 2020-01-02 | Simon Barry J. Director | Grant or award · Stock Option (right to buy) | +9,600 | 9,600 |
Page 13 of 17 · 323 trades